Nasal Spray for Eosinophilic Asthma
Part of Blood & lymphatic, Lungs & breathing clinical trials.
This study tests an investigational nasal spray called AD17002 for people with eosinophilic asthma (a type of asthma with high eosinophil levels). Participants will use the spray themselves at home to see if it can help control their asthma safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have had asthma for at least 6 months.
- Your blood eosinophil count is at least 150 cells/µL (a type of white blood cell linked to asthma inflammation).
- You do not have other serious lung diseases like COPD, cystic fibrosis, or active tuberculosis.
- You have not used high-dose oral steroids (more than 7.5 mg prednisone daily) in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral medication called KT-621 for people with moderate to severe eosinophilic asthma. It aims to see if the drug can help control asthma better than the standard inhaled treatments alone.
This study tests if adding a new injectable medicine (benralizumab) to your current medium-dose inhaler works better than simply increasing your inhaler dose to control hard-to-treat asthma. It may help people with a specific type of asthma linked to high eosinophil levels.
This trial studies different types of eosinophil cells in people with asthma, eosinophilic granulomatosis with polyangiitis (EGPA), or hypereosinophilic syndrome (HES). It also includes healthy volunteers. The goal is to better understand these cells in each condition.
This study looks at how certain immune cells (eosinophils) work in people with asthma. It compares people with mild to severe asthma, including those who have or haven't taken biologic treatments, against people without asthma. The goal is to better understand asthma and find new ways to treat it.
This trial tests a new medicine called SHR-1703 for people with eosinophilic asthma (a type of asthma with high levels of certain white blood cells). It looks at how safe the medicine is over time and if it helps control asthma attacks. You must already be using medium or high dose inhaled steroids plus another asthma medicine, and have had at least one asthma attack in the past year.
This trial tests if an investigational nasal spray (ETH47) can reduce asthma symptoms triggered by a common cold virus (rhinovirus). You will be exposed to the virus in a safe setting to see if the spray helps control your asthma.
Hear when a new Eosinophilic Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.